Tempus AI, Inc. (NASDAQ:TEM) CEO Eric P. Lefkofsky Sells 476,209 Shares

Tempus AI, Inc. (NASDAQ:TEM) CEO Eric P. Lefkofsky sold 476,209 shares of the stock in a transaction that occurred on Wednesday, January 22nd. The shares were sold at an average price of $49.84, for a total transaction of $23,734,256.56. Following the sale, the chief executive officer now directly owns 6,502,643 shares of the company’s stock, valued at approximately $324,091,727.12. This trade represents a 6.82 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink.

Tempus AI Price Performance

TEM traded down $3.44 during trading on Friday, reaching $51.40. The company had a trading volume of 12,994,864 shares, compared to its average volume of 9,294,415. The company has a quick ratio of 2.55, a current ratio of 2.69 and a debt-to-equity ratio of 8.17. The business has a 50 day simple moving average of $44.38 and a 200-day simple moving average of $47.46. Tempus AI, Inc. has a 52 week low of $22.89 and a 52 week high of $79.49.

Analysts Set New Price Targets

TEM has been the topic of a number of research reports. Wolfe Research started coverage on shares of Tempus AI in a report on Friday, December 13th. They issued an “outperform” rating and a $60.00 price target on the stock. Guggenheim initiated coverage on Tempus AI in a research report on Monday, December 9th. They issued a “buy” rating and a $74.00 target price on the stock. Bank of America raised their price target on Tempus AI from $52.00 to $54.00 and gave the company a “neutral” rating in a report on Friday, December 13th. Needham & Company LLC reaffirmed a “buy” rating and set a $56.00 price objective on shares of Tempus AI in a report on Tuesday, January 14th. Finally, Loop Capital lowered their target price on Tempus AI from $57.00 to $52.00 and set a “buy” rating for the company in a research report on Tuesday, January 14th. Three investment analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company’s stock. According to MarketBeat.com, Tempus AI presently has an average rating of “Moderate Buy” and a consensus price target of $56.36.

Institutional Investors Weigh In On Tempus AI

Several institutional investors have recently made changes to their positions in TEM. abrdn plc bought a new stake in shares of Tempus AI during the 4th quarter worth approximately $2,784,000. Renaissance Capital LLC increased its stake in Tempus AI by 121.3% in the fourth quarter. Renaissance Capital LLC now owns 24,757 shares of the company’s stock worth $836,000 after purchasing an additional 13,569 shares during the period. China Universal Asset Management Co. Ltd. bought a new stake in shares of Tempus AI during the fourth quarter worth $1,091,000. Exchange Traded Concepts LLC boosted its stake in shares of Tempus AI by 37.8% during the fourth quarter. Exchange Traded Concepts LLC now owns 84,174 shares of the company’s stock valued at $2,842,000 after purchasing an additional 23,070 shares during the period. Finally, SG Americas Securities LLC purchased a new stake in shares of Tempus AI during the fourth quarter valued at $372,000. Institutional investors own 24.22% of the company’s stock.

About Tempus AI

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.